MS Society Information Webinar – Challenging preconceptions of MS
A new information webinar from the MS Society
MS Society Information Webinar – Challenging preconceptions of MS Read More »
About MS
A new information webinar from the MS Society
MS Society Information Webinar – Challenging preconceptions of MS Read More »
We are delighted to receive another guest blog from Physiotherapist, Henriette.
Guest blog post from Henriette in Denmark – Exercise for life Read More »
Source MS Trust: This week is Mental Health Awareness Week. The MS Trust is taking a look at how MS can affect our mental health as well as some positive steps you can take to help with your wellbeing.
Mental Health Awareness Week Read More »
Source MS Society: In April 2021 the MS Society launched their new, improved forum. Here’s everything you need to know about the change.
MS Society have launched their new forum Read More »
Source MS Society: We’re pleased to introduce Octopus – our revolutionary, multi-arm, multi-stage trial that will transform the way we test treatments for progressive MS.
Introducing Octopus – the world’s first multi-arm, multi-stage trial for MS Read More »
Source MS Society: The Medicines and Healthcare products Regulatory Agency (MHRA), and European Commission (EC) have licenced ofatumumab to treat adults with active relapsing MS.
Ofatumumab licensed for active relapsing-remitting MS in UK Read More »
Source MS Society: Following the recent announcement about the Oxford-AstraZeneca vaccine: The news might affect you if you’re under 30 and you live with someone with MS.
Oxford-AstraZeneca vaccine: Under 30 and live with someone with MS? Read More »
We are delighted that Henriette has written a guest blog post for us and also a link to her new blog in Denmark.
Guest blog post from Henriette in Denmark – How to celebrate exercise success Read More »
Source The Guardian: Researchers will test several drugs at once to speed up identification of those that slow or reverse symptoms
UK to test existing drugs as treatment for MS in world-first trial Read More »